Skip to main content

UM School of Medicine's Myron M. Levine, MD, DTPH, to Receive Prestigious Lifetime Award for Five Decades of Pioneering Vaccine Research

October 30, 2019 | Joanne Morrison

Myron M. Levine, MD, DTPH

Dr. Levine will be Honored by Research!America with the 2020 Geoffrey Beene Foundation Builders Science Award

Myron M. Levine, MD, DTPH, the Simon and Bessie Grollman Distinguished Professor at the University of Maryland School of Medicine (UMSOM), Associate Dean for Global Health, Vaccinology and Infectious Diseases, and Founder and Former Director of the Center for Vaccine Development and Global Health (CVD) is a co-recipient of the 2020 Research! America Geoffrey Beene Foundation Builders of Science Award for his pioneering vaccine and infectious disease research.

This lifetime achievement award recognizes the significant impact Dr. Levine’s vaccine research, which spans nearly 50 years, has had in protecting the world’s most vulnerable populations from critical diseases like typhoid, cholera and Shigella dysentery.

The 24th Research!America Advocacy Awards, to be held at the Andrew W. Mellon Auditorium in Washington, D.C. on March 11, 2020, brings together leaders from government, industry, academia, patient groups, scientific societies, independent research institutes, and health advocacy organizations to honor exceptional advocates for research.

“No one deserves this honor more than Dr. Levine,” said UMSOM Dean E. Albert Reece, MD, PhD, MBA, Executive Vice President for Medical Affairs, UM Baltimore, and the John Z. and Akiko K. Bowers Distinguished Professor. “We are so delighted that Research! America will grant this most prestigious award to one of UMSOM’s most distinguished leaders. For nearly half a century, Dr. Levine has pioneered important vaccine and infectious disease research on the world’s most challenging diseases. The benefits of his research have impacted millions of lives around the globe,” said Dean Reece.

Since 1970, Dr. Levine has worked on vaccine research and is widely recognized as a pioneer of the discipline of “vaccinology.” After founding CVD in 1974, he served as Director until 2015. He oriented CVD to fill the niche of developing vaccines to prevent certain infections that have enormous disease burdens in impoverished populations and developing countries, but cause little burden in the U.S. and other industrialized countries. This includes research to develop vaccines against intestinal infections such as cholera, Shigella dysentery, typhoid fever, and non-typhoidal Salmonella infections.

“I am deeply honored to be a recipient of the Geoffrey Beene Foundation Builders of Science Award. However, my research accomplishments have been team efforts with dedicated research collaborators both at CVD in the USA and with colleagues abroad, particularly, over many years in Chile and Mali. In accepting this award, I wish to acknowledge my colleagues who not only contributed to the research accomplishments but who have provided treasured friendships over the decades,” said Dr. Levine.

Widely Recognized Global Health Research

Dr. Levine has spent considerable time working in developing countries on the epidemiology and prevention of enteric infections. His 50-year research career has covered basic vaccine development, clinical trials (safety, immunogenicity, and efficacy), and impact following vaccine introduction. He has trained vaccine researchers globally.

“Mike is one of the leading vaccinology researchers in the world, and his impact on public health is immeasurable.  He richly deserves this award,” said Kathleen Neuzil, MD, MPH, Professor of Medicine and Pediatrics and Director of the Center for Vaccine Development and Global Health.

At UMSOM, Dr. Levine founded CVD, received 18 patents, and led research to the development of the only Food and Drug Administration Approved Cholera Vaccine for U.S. adults. He is currently the Principal Investigator for research in Samoa aimed at ultimately eradicating Typhoid, Principal Investigator for NIH- funded research into antimicrobial resistance and Principal Investigator for Bill and Melinda Gates Foundation-funded research into diarrheal diseases.

Dr. Levine’s research is widely recognized. In 1995, he was elected to the National Academy of Medicine of the National Academy of Sciences. In 2017 he was awarded the Maxwell Finland Award for Scientific Achievement by the National Foundation for Infectious Diseases (NFID), honoring his extensive accomplishments in public health and identifying solutions to major sources of disease in the developing world, including cholera, typhoid, and Shigella dysentery.

He is clinically trained in pediatrics and pediatric infectious diseases and is also trained in tropical public health and epidemiology. He received post-graduate laboratory training in microbiology and immunology of bacterial infections. His global health research includes serving as a World Health Organization (WHO) consultant to the Smallpox Eradication Program in Bangladesh in 1975, where he was District Coordinator for Rajshahi District. From 2000 to 2002, he was a member of the first Working Group of the Global Alliance for Vaccines and Immunization (now called the GAVI Alliance), and was co-chair of its Task Force on Research and Development.

Dr. Levine has published more than 682 peer reviewed papers, 121 book chapters and is Senior Editor of New Generation Vaccines, a textbook of research vaccinology. In addition, he has 18 patents. He has also served in important leadership roles in the field of infectious disease, such as President of the American Epidemiological Society and the American Society of Tropical Medicine and Hygiene (ASTMH). He has received many awards and honors for his contributions to the field of vaccinology including: Albert B. Sabin Gold Medal Award of the Albert B. Sabin Vaccine Institute (1998) for contributions to the field of vaccinology; Medalla Rectoral of the University of Chile (2006); Maurice Hilleman/Merck Award of the American Society for Microbiology for lifelong contributions to vaccinology (2012); Donald Mackay Medal of the ASTMH in recognition of outstanding research on tropical health (2013); Dean’s Distinguished Gold Medal, UMSOM (2014); American College of Physicians Award for Outstanding Work in Science as Related to Medicine (2015); National Foundation for Infectious Diseases Maxwell Finland Award for Scientific Achievement (2017). In 2005 the President of Mali awarded him the National Order of Mali, Grand Officer rank.

He received his BS Degree from City College of New York, his MD Degree from the Medical College of Virginia and his Diploma in Tropical Public Health (with distinction) from the London School of Hygiene and Tropical Medicine. Dr. Levine then trained in pediatrics and pediatric infectious diseases at Bronx Municipal Hospital Center, Albert Einstein College of Medicine. Thereafter, he served as an Epidemic Intelligence Service Officer at the Centers for Disease Control & Prevention (CDC).

About Research!America

Research!America is the nation’s largest nonprofit public education and advocacy alliance working to make research to improve health a higher national priority. Founded in 1989, Research!America is supported by member organizations that represent the voices of 125 million Americans. The Research!America alliance advocates for science, discovery, and innovation to achieve better health for all. Together, with its member organizations that represent a vast array of medical, health and scientific fields, Research! America’s goals are to Achieve funding for medical and health research from the public and private sectors at a level warranted by scientific opportunity and supported by public opinion; Better inform the public of the benefits of medical and health research and the institutions that perform research; Motivate the public to actively support medical and health research and the complementary sciences that make advances possible; and promote and empower a more active public and political life by individual members of the research community on behalf of medical and health research, public health, and science overall. Dean Reece serves as a member of Research!America’s Executive Committee. Visit www.researchamerica.org.

About the University of Maryland School of Medicine

Now in its third century, the University of Maryland School of Medicine was chartered in 1807 as the first public medical school in the United States. It continues today as one of the fastest growing, top-tier biomedical research enterprises in the world -- with 43 academic departments, centers, institutes, and programs; and a faculty of more than 3,000 physicians, scientists, and allied health professionals, including members of the National Academy of Medicine and the National Academy of Sciences, and a distinguished recipient of the Albert E. Lasker Award in Medical Research.  With an operating budget of more than $1 billion, the School of Medicine works closely in partnership with the University of Maryland Medical Center and Medical System to provide research-intensive, academic and clinically based care for more than 1.2 million patients each year. The School has over 2,500 students, residents, and fellows, and more than $540 million in extramural funding, with most of its academic departments highly ranked among all medical schools in the nation in research funding. As one of the seven professional schools that make up the University of Maryland, Baltimore campus, the School of Medicine has a total workforce of nearly 7,000 individuals. The combined School and Medical System (“University of Maryland Medicine”) has an annual budget of nearly $6 billion and an economic impact more than $15 billion on the state and local community. The School of Medicine faculty, which ranks as the 8th highest among public medical schools in research productivity, is an innovator in translational medicine, with 600 active patents and 24 start-up companies. The School works locally, nationally, and globally, with research and treatment facilities in 36 countries around the world. Visit medschool.umaryland.edu

 

Contact

Joanne Morrison
Director of Marketing and Public Relations
Center for Vaccine Development and Global Health
University of Maryland School of Medicine
jmorrison@som.umaryland.edu
Office: (410) 706-2884
Mobile: (202) 841-3369

Related stories

    Monday, October 21, 2019

    UM School of Medicine's Kathleen M Neuzil Elected as Member of Prestigious National Academy of Medicine

    Kathleen M. Neuzil, MD, MPH, Professor of Medicine and Pediatrics and Director of the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine (UMSOM), has been elected as a member of the National Academy of Medicine (NAM), in recognition of her pivotal research that has informed and shaped global vaccine and public health policy. Her membership was announced at the annual NAM meeting in Washington, D.C., placing her among the 2,178 U.S. members of this important organization. Membership in the Academy is considered one of the highest honors for individuals who have made major contributions to the advancement of the medical sciences, health care and public health.


    Monday, August 19, 2019

    UM School of Medicine Researcher Warns of Need for Malaria Drug to Treat Severe Cases in U.S.

    Each year there are more than 200 million cases of malaria worldwide, a mosquito-borne disease caused by a parasite that brings on fever and body aches and, in some cases, more serious conditions such as coma and death. While the vast majority of these cases occur in sub-Saharan Africa and South Asia, the U.S. each year sees more than 1,500 cases, and currently there is limited access to an intravenously-administered (IV) drug needed for the more serious cases, according to a top malaria researcher at the University of Maryland School Medicine (UMSOM).


    Wednesday, July 17, 2019

    Vaccines Tested in UM School of Medicine’s Center for Vaccine Development Protect Children Around the World

    For 30 years, the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine (UMSOM) has collaborated with the Pediatric Center of Frederick to test vaccines used in pediatric care.


    Friday, March 08, 2019

    UMSOM Researchers Unveil Progress and Challenges in Introducing Typhoid Conjugate Vaccine in Sub-Saharan Africa and Asia

    Each year there are nearly 11 million cases of typhoid, a disease that is spread through contaminated food, drink and water. Researchers at the University of Maryland School of Medicine are leading an international consortium that is studying the impact of a typhoid conjugate vaccine (TCV) in an effort to accelerate introduction of the vaccine in countries in sub-Saharan Africa and Asia where there is a high burden of typhoid.


    Wednesday, December 26, 2018

    Multicenter Trial Supports Use of Topical Antibiotic as a Tool to Eliminate Staph Colonization in NICU Babies

    A team of doctors led by Karen L. Kotloff, M.D., University of Maryland School of Medicine (UMSOM), Center for Vaccine Development and Global Health (CVD), has performed a clinical trial involving multiple hospitals that tested the effectiveness of applying a topical antibiotic known as mupirocin for prevention of Staphylococcus aureus (SA) infection in babies in the neonatal intensive care unit (NICU). This study was published in the journal Pediatrics.


    Thursday, December 20, 2018

    Data From Largest Global Diarrheal Disease Study Available to Scientists on Public Sites

    Data collected from the Global Enteric Multicenter Study (GEMS), a multi-site research project studying diarrheal diseases that was designed and coordinated by researchers in the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine (UMSOM), are now available to scientists on two online data resources.


    Monday, December 03, 2018

    UMSOM and Groupe De Recherche Action En Sante Begin Second Typhoid Conjugate Vaccine Study in Africa

    A new study has been launched in Burkina Faso for Bharat Biotech’s typhoid conjugate vaccine (TCV). It is the second clinical study underway in Africa for the vaccine and the first in West Africa. The vaccine study is a joint effort by the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine, (UMSOM) and Groupe de Recherche Action en Santé (GRAS) in Burkina Faso.


    Friday, November 02, 2018

    UMSOM Global Health Expert Named to Prestigious World Health Organization Immunization Panel

    Kathleen Neuzil, MD, MPH, Professor of Medicine and Pediatrics and Director of the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine (UMSOM), has been named to the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) on Immunization.


    Sunday, October 28, 2018

    American Society of Tropical Medicine & Hygiene Awards Dr. Miriam Laufer the LePrince Medal for Malaria Research

    Miriam Laufer, MD, MPH, Professor of Pediatrics and Associate Director for Malaria Research at the University of Maryland School of Medicine’s (UMSOM) Center for Vaccine Development and Global Health (CVD), was awarded the Joseph Augustin LePrince Medal by the American Society of Tropical Medicine and Hygiene (ASTMH).


    Thursday, June 08, 2017

    University of Maryland School of Medicine Vaccine Researcher Receives Top Award in the Study of Infectious Diseases from National Foundation

    Myron M. Levine, MD, DTPH, the Simon and Bessie Grollman Distinguished Professor and Associate Dean for Global Health, Vaccinology and Infectious Disease at UM SOM, has been awarded the Maxwell Finland Award for Scientific Achievement by the National Foundation for Infectious Diseases (NFID).


    Monday, May 15, 2017

    UM SOM Vaccine Researcher Receives Top Award in the Study of Infectious Diseases

    Myron M. Levine, MD, DTPH, the Simon and Bessie Grollman Distinguished Professor and Associate Dean for Global Health, Vaccinology and Infectious Disease at UM SOM, has been awarded the Maxwell Finland Award for Scientific Achievement by the National Foundation for Infectious Diseases (NFID). The award honors his extensive accomplishments in public health; over his career, he has identified solutions to major sources of disease in the developing world, including cholera, typhoid, and Shigella dysentery. The award will be presented on Thursday, May 18, 2017 at the Hyatt Regency Bethesda in Bethesda, Md.


    Friday, December 23, 2016

    Trial Results Confirm Ebola Vaccine Provides High Protection Against Disease

    An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to a new study that included researchers from the University of Maryland School of Medicine (UM SOM).


    Friday, June 10, 2016

    FDA Approves Vaccine for Cholera Invented and Developed at University of Maryland School of Medicine

    In a milestone that was years in the making, a vaccine to prevent cholera, invented and developed by researchers at the University of Maryland School of Medicine’s Center for Vaccine Development, was approved today by the U.S. Food and Drug Administration (FDA).


    Tuesday, April 28, 2015

    Myron M. Levine Receives Award from American College of Physicians

    Myron M. Levine, MD, DTPH, the University of Maryland School of Medicine’s Associate Dean for Global Health, Vaccinology and Infectious Diseases, has been awarded the American College of Physicians Award for Science for Outstanding Work in Science as Related to Medicine. The American College of Physicians (ACP) is the national organization of internists. Prof. Levine will receive the award April 30 at the group’s Internal Medicine Meeting 2015 in Boston.